Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers
Source: SeekingAlpha
2026-01-15 07:10:00 ET
More on Disc Medicine, Sanofi, etc.
- Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Sanofi multiple sclerosis therapy rejected by the FDA
- Sanofi, Regeneron’s Dupixent approved in Japan for children with asthma
Read the full article on Seeking Alpha
For further details see:
Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers
Achieve Life Sciences Inc.
NASDAQ: ACHV
ACHV Trading
-2.55% G/L:
$4.0929 Last:
214,986 Volume:
$4.18 Open:
ACHV Latest News
ACHV Stock Data
$234,761,887
51,636,968
N/A
28
N/A
Biotechnology & Life Sciences
Healthcare
CA
Bothell
